Definitive Contract HDTRA117C0028

Award Date 8/25/17
Potential Completion Date 8/24/21
Potential Value $3.9M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
19
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Threat Reduction Agency awarded a $4,387,571.00 Cost Plus Fixed Fee contract to the Ministry of Defence, doing business as D S T L, a U.K. government entity located in Great Britain. The contract is for the development of chemical and biological decision support tools, with a completion date of July 21, 2022. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, and may involve activities such as research on medical...
This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...
This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...
The Defense Threat Reduction Agency (DTRA) awarded a $1.1 million cost-plus-fixed-fee delivery order contract to the Ministry of Defence, doing business as DSTL, for work under its AD92 program. To be performed in Great Britain from December 2015 through March 2018, this contract calls for DSTL to provide unspecified services to DTRA in support of the agency's counter-weapons-of-mass-destruction efforts. As the prime contractor, DSTL will leverage its expertise conducting scientific research and...
This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as D S T L (Defence Science and Technology Laboratory), a United Kingdom government entity. The contract is for research and development of pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This award is not associated with a set-aside program. The original solicitation was a...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The $1,104,374.25 contract is for diagnostic meta-analysis research, with a period of performance ending on September 30, 2021. As a foreign government entity, DSTL has a proven track record of securing contracts from U.S. federal agencies, including DTRA and the...
This is a $2,758,080.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (doing business as D S T L), a United Kingdom government entity. The contract is for the project "HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)" and has a March 30, 2023 completion date. The contract was awarded on December 10, 2018 and was not set aside for any special designation. D S T L, as a foreign government...
This is a $775,339.30 cost-plus-fixed-fee definitive contract awarded to the Ministry of Defence (operating as D S T L), a government entity in the United Kingdom, by the U.S. Army's Research, Development and Engineering Command. The contract is for the STRIDER ENHANCEMENT program, and does not have a set-aside designation. Based on D S T L's past federal contract work, the contract likely involves research and development services related to countering chemical, biological, radiological, and...
This is a $6,400,448.87 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence of the United Kingdom, doing business as the Defence Science and Technology Laboratory (D S T L). The contract is for the development of non-ionic surfactant vesicles (NISVs) as a drug delivery and targeting system for antimicrobials. This contract was awarded under a Broad Agency Announcement (BAA) that solicited proposals for innovative research and...
The Department of Homeland Security Science and Technology Directorate awarded a $1.922 million other transaction agreement to the Ministry of Defence, doing business as D S T L, located in Great Britain, United Kingdom. This contract is to support the Directorate's Innovative Research Call 2020 program through June 2025. Under the agreement, D S T L will provide research and development services to advance the Science and Technology Directorate's mission to deliver effective and relevant...

The U.S. Defense Threat Reduction Agency awarded a $3,922,194.00 cost-plus-fixed-fee definitive contract to the Ministry of Defence, doing business as DSTL, located in the United Kingdom. The contract is for the CRYSTALCAST TOOLSET and has an ultimate completion date of August 24, 2021. The contract has no set-aside designation. Based on the agency and the nature of the work, this contract supports the Defense Threat Reduction Agency's efforts to counter chemical, biological, radiological, and nuclear threats through research and development services, including developing medical countermeasures, diagnostic tools, and decision support systems.

Generated 10/17/24, 9:36 AM